Menetelmä fuusioproteiinin valmistamiseksi

摘要

The invention relates to a process for the preparation of a fusion protein with both interleukin-2 and hirudin activity by expressing a gene that codes either the C or N terminus which corresponds substantially with the amino acid sequence of interleucin-2, and which also codes hirudin, in a suitable host cell.